New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
Ontology highlight
ABSTRACT: The causes of Parkinson disease (PD) remain mysterious, although some evidence supports mitochondrial dysfunctions and α-synuclein accumulation in Lewy bodies as major events. The abnormal accumulation of α-synuclein has been associated with a deficiency in the ubiquitin-proteasome system and the autophagy-lysosomal pathway. Cathepsin D (cathD), the major lysosomal protease responsible of α-synuclein degradation was described to be up-regulated in PD model. As glycosaminoglycans (GAGs) regulate cathD activity, and have been recently suggested to participate in PD physiopathology, we investigated their role in α-synuclein accumulation by their intracellular regulation of cathD activity. In a classical neuroblastoma cell model of PD induced by MPP+, the genetic expression of GAGs-biosyntheti
SUBMITTER: Lehri-Boufala S
PROVIDER: S-EPMC4305359 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA